The evolution of Extravascular Cardioverter Defibrillator implantation: feasibility in a purely electrophysiologic setting

Clicks: 18
ID: 325405
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #110 of 138 articles by views in EP Europace

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 138 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
BACKGROUND: extravascular implantable cardioverter-defibrillator (EV-ICD) is a novel non-transvenous system delivering defibrillation shocks and anti-tachycardia pacing through a substernal lead. Despite proven efficacy, implantation has traditionally required general anesthesia and cardiothoracic surgical backup, limiting widespread adoption. OBJECTIVES: To evaluate feasibility, safety, and workflow efficiency of EV-ICD implantation under cardiologist-directed sedation without anesthesiology support. METHODS: Prospective observational study including 115 consecutive patients undergoing EV-ICD implantation across two European centers. Three procedural settings were explored sequentially: general anesthesia (GA, n=46), analgosedation without anesthesiology supervision (AS, n=28), and regional block with limited sedation (RBS, n=41). The primary endpoint was successful implantation without conversion to respiratory or circulatory support. Secondary endpoints included procedure duration, procedure-related complications, and device performance at follow-up. RESULTS: Overall implantation success was 97% (112/115) in a predominantly young population (50±17 years; 70% male). All procedures performed without anesthesiology supervision were completed without conversion to GA or emergency support, with comparable complication rates across groups. RBS was associated with a 27-minute reduction in procedural duration versus GA (p<0.001) and earlier mobilization (97% ambulating within 3 hours vs. 65% after 6 hours with GA; p<0.001). Over a median follow-up of 20 [10-30] months, appropriate ICD therapy was delivered in 13% of patients with 100% arrhythmia termination. Inappropriate therapy occurred in 8.9%, predominantly during the early learning phase. CONCLUSIONS: EV-ICD implantation can be safely and effectively performed under cardiologist-directed sedation without anesthesiology supervision, achieving a fully electrophysiology-driven workflow. Procedural simplification substantially reduces resource utilization and may facilitate broader adoption of this technology.
Reference Key
openalex_W7203738832 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal EP Europace
Year 2026
DOI
10.1093/europace/euag217
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.